The tumor suppressor p53 plays a pivotal role in regulating cellular processes governing cell cycle arrest, apoptosis and senescence. Central to regulation of p53 is the activity of two negative regulators, Mdm2 and Mdmx. The prevailing model for regulation of p53 suggests that Mdm2 is involved in regulating p53 protein stability while Mdmx regulates p53 transcriptional activity (1) . Mdm2 and Mdmx elicit their effects largely based on phosphorylation status to modulate their protein interactions.
Kinase activity in response to DNA damage leads to phosphorylation of Mdm2 and Mdmx ultimately stabilizing p53 and leading to its transcriptional activation (2, 3) . Phosphorylation of Mdm2 by ATM blocks nuclear export of p53 (4) and prevents poly-ubiquitination of p53 by inhibiting Mdm2 RING domain homodimerization (5) . In addition, ATM and Chk2 phosphorylation of Mdmx rapidly destabilizes Mdmx (6) (7) (8) (9) . c-Abl kinase is activated by ATM in response to DNA damage (10) and phosphorylates Mdm2 and Mdmx. c-Abl phosphorylation of Mdm2 stabilizes p53 and promotes apoptosis (11, 12) whereas c-Abl phosphorylation of Mdmx activates p53 by blocking Mdmx-p53 complex formation (13) .
Mdm2 and Mdmx associate via their RING domains (14) and phosphorylation near the RING domains is predicted to alter oligomerization and is associated with stabilization of p53. This model is supported by recent findings that Wip1, which dephosphorylates Mdm2 and Mdmx, inhibits p53 activity (15, 16) . The oligomerization of Mdm2 and Mdmx has garnered attention recently as growing evidence suggests that this serves as a regulatory mechanism. Several studies have shown that Mdmx stabilizes Mdm2 in cells and prevents Mdm2-mediated degradation of p53 (17) (18) (19) while over-expressed Mdmx promotes p53-dependent apoptosis (20) . However, the presence of Mdm2 and Mdmx together in vitro and in vivo has the potential to degrade p53 (21, 22) . These seemingly conflicting results appear to depend on the stoichiometric balance of Mdm2 and Mdmx. Drawing from structural modeling and in vitro ubiquitin ligase assays, it has been suggested that E2 recruitment to Mdm2 homo-oligomers would auto-ubiquitinate Mdm2 whereas Mdm2-Mdmx hetero-oligomers would preferentially ubiquitinate substrates (23) . While molecular modeling provides useful insights into the process of E2 recruitment, experimental evidence to support this model has yet to be substantiated. However these studies do point to the importance of understanding the oligomerization of Mdm2 and Mdmx.
The biochemical mechanism and functional importance for Mdm2 homo-oligomerization has been demonstrated (5) but the process that underlies the formation of Mdm2-Mdmx complexes remains unclear. Here we investigate Mdm2-Mdmx complex formation as a consequence of DNA damage signaling. We show that Mdm2-Mdmx complex formation is augmented by c-Abl phosphorylation of Mdm2. Inhibiting c-Abl activity, through a dominantnegative Abl mutant or the selective inhibitor imatinib, leads to a decrease in Mdm2-Mdmx complex formation. Study of c-Abl signaling using c-Abl -/-knockout primary MEFs (24) recapitulated these findings and exhibited a decrease in Mdmx ubiquitination in response to DNA damage. In addition, p53 was not as robustly induced in c-Abl -/-MEFs after genotoxic stress. These data form a link between DNA damage signaling and Mdm2-Mdmx complex formation that is important for regulating Mdm2 activity.
EXPERIMENTAL PROCEDURES
Cell culture and treatments-Mammalian cells were cultured at 37°C in a humidified incubator with 5% CO 2 in DMEM high glucose plus 10% FBS. c-Abl -/-and control primary murine embryonic fibroblasts (MEFs) (24) were cultured in the same media plus non-essential amino acids. Transfections were performed using Lipofectamine and Plus reagent (Invitrogen). Equal amounts of DNA of human origin (HAMdm2 (2µg), Myc-Mdmx (4µg), Abl and KD Abl (2µg) plus control plasmid) were transfected into cells for 4 h in IMDM without serum. Medium was replaced with normal growth medium and incubated 18-20 h prior to analysis. For the luciferase assays, H1299 cells were transfected with 50ng of p53, 1µg of HA-Mdm2, 500ng β -galactosidase and 100ng PG13-luc plasmid using the calcium phosphate method. Reporter activity was normalized to β-galactosidase. Doxorubicin (Sigma) was used at 5µM and imatinib (LC laboratories) was used at 10µM or as indicated in DMEM 1% FBS. Site-directed mutagenesis was performed by PCR and constructs were sequenced in their entirety.
shRNA to c-Abl (5'-GACCAACTTGTTCAGCGCC-3') and scramble control sequences (25) 
RESULTS

DNA damage augments Mdm2-Mdmx complex
formation. Mdm2 and Mdmx are capable of forming hetero-oligomeric complexes. Studies have suggested somewhat conflicting results for the functional role of Mdm2-Mdmx complexes in regulation of p53. However, the requirement for the formation of Mdm2-Mdmx complexes in cellbased assays has not been addressed. c-Abl has been shown to phosphorylate Mdm2 and lead to stabilization of p53 (11, 12) . We hypothesized that phosphorylation of Mdm2 by c-Abl would affect Mdm2-Mdmx complex formation as a mechanism for functional inactivation of Mdm2. To test this hypothesis, we examined the conditions that favor the formation of Mdm2-Mdmx complexes. We employed a co-immunoprecipitation approach following treatment with 5µM doxorubicin, a topoisomerase II inhibitor that results in single and double strand DNA breaks and is known to activate c-Abl. It has been shown that Mdm2 levels are independent of p53 regulation under these conditions (26) and other forms of severe genotoxic stress (27) . This level of DNA damage allowed us to investigate Mdm2 phosphorylation without p53-mediated transcription of Mdm2. 293T cells were transfected with expression plasmids for HA-Mdm2 and Myc-Mdmx. Immunoprecipitation of Myc-Mdmx showed a significant increase in the level of co-purification with HA-Mdm2 after DNA damage (Fig. 1A , lane 2). Counter blot for Myc showed equivalent immunoprecipitation of Myc-Mdmx. The whole cell extracts (WCEs) showed no difference in expression levels after 2 h doxorubicin. Control immunoprecipitations using normal mouse IgG demonstrate specificity in our assays. To examine endogenous Mdm2-Mdmx complex formation, Mdm2 was immunoprecipitated from control and doxorubicin treated MCF-7 cells. Consistent with the over-expression experiments, a significant increase in endogenous Mdm2-Mdmx copurification was observed in response to DNA damage (Fig. 1B, lane 2) . Counter blot for Mdm2 showed equivalent immunoprecipitation. Again, the WCEs showed no difference in protein expression after 2 h doxorubicin and control immunoprecipitations using normal mouse IgG show specificity in these experiments.
Mdm2 and Mdmx are substrates of c-Abl and c-Abl plays an important role in the DNA damage response (28) . In MCF-7 cells treated with doxorubicin, c-Abl is activated by 4 h with a maximal response at 8 h, as determined by phosphorylation at Y245 (29) . Under these conditions, Mdm2 and Mdmx proteins are present at high levels at 2 h (Fig. 1C) . Additionally, activation of c-Abl preceded destabilization of both Mdm2 and Mdmx and was concomitant with accumulation of p53 (30) (Fig. 1C) . Further, p53 induced the downstream target, p21 under these conditions. These data show that DNA damage leads to a significant increase in Mdm2-Mdmx complex formation and that under these conditions c-Abl is activated.
Abl phosphorylation of Mdm2 increases Mdm2-Mdmx complex formation in vitro.
To directly test the importance of Abl phosphorylation of Mdm2 in Mdm2-Mdmx complex formation, we employed an ELISA-based approach to measure the relative binding of recombinant Mdm2 and Mdmx proteins. Abl phosphorylated Mdm2 (Mdm2-P) exhibited a greater than 4-fold increase in binding to Mdmx over un-phosphorylated Mdm2. Whereas Abl phosphorylation of Mdm2 played a role in complex formation, phosphorylation of Mdmx (Mdmx-P) did not affect complex formation (13) (Fig. 2A) . Co-immunoprecipitation of recombinant Mdm2 with Mdmx recapitulated the increase in complex formation following Abl phosphorylation of Mdm2 (Fig. 2B, lane 2) . Counter blot showed equivalent immunoprecipitation of Mdm2. To confirm the presence of Abl modification on Mdm2 we also re-probed the blot for phosphotyrosine residues.
32 P incorporation using γ 32 P-ATP in our kinase reactions confirmed that Abl efficiently phosphorylated Mdm2. Autophosphorylation of Abl served as an internal control for the reaction (Fig. 2C) . These data define a direct link between Abl phosphorylation (Fig. 1C) . To investigate the cellular role of c-Abl in Mdm2-Mdmx complex formation, 293T cells were transfected with HA-Mdm2, Myc-Mdmx and either wild type Abl or kinase dead (KD) Abl (K290R dominant negative) (31) . Immunoprecipitation of MycMdmx showed a significant decrease in the level of HA-Mdm2 co-purification when KD Abl was expressed (Fig. 3A, compare lanes 2 & 4) . Counter blot showed equivalent immunoprecipitation of Myc-Mdmx in these samples. To extend this result and test the role of c-Abl in endogenous Mdm2-Mdmx complex formation we used the selective inhibitor, imatinib (32) . MCF-7 cells were treated with increasing concentrations of imatinib for 2 h. At high dose, imatinib led to a modest decrease in the level of endogenous Mdm2-Mdmx complex formation (Fig. 3B, lane 3) . The levels of Mdm2 and Mdmx in WCEs used for immunoprecipitation remained unchanged. Control immunoprecipitations using normal rabbit IgG demonstrate specificity in this assay.
To further address the importance of c-Abl signaling in vivo, c-Abl -/-knockout primary murine embryonic fibroblasts (MEFs) (24) were used to probe Mdm2-Mdmx complex formation. In response to DNA damage, coimmunoprecipitation of endogenous Mdm2 with Mdmx was significantly reduced in MEFs lacking c-Abl compared to control MEFs (Fig. 3C, lane 1) . Counter blot for Mdm2 showed an equivalent level of Mdm2 immunoprecipitation in the MEFs. These data show, in a cellular context, a direct link between c-Abl kinase activity and an increase in Mdm2-Mdmx complex formation.
Multi-site phosphorylation of Mdm2 is required for maximal Mdm2-Mdmx complex formation.
Mdm2 has three known c-Abl phosphorylation sites (Y276, Y394 and Y405) (11, 12) . Considering that two of these lie proximal to the RING domain we tested the importance of these three sites in Mdm2-Mdmx complex formation. A series of phenylalanine mutants of HA-Mdm2 were generated to each site individually (Y276F, Y394F and Y405F) or in combination (Y276/394F and Y276/394/405F) to target c-Abl phosphorylation sites (Fig. 4A) . If c-Abl phosphorylation is important for Mdm2-Mdmx complex formation then we would expect to see a decrease in Mdm2-Mdmx co-purification with these mutants. Expression of these mutants with Myc-Mdmx and c-Abl in 293T cells revealed a cooperative effect of Y276 and Y394 in formation of Mdm2-Mdmx complexes. Immunoprecipitation of Myc-Mdmx exhibited a significant decrease in the level of HAMdm2 co-purification with the double mutant Y276/394F compared to wild-type HA-Mdm2 (Fig. 4B, lane 5) . The counter blot shows equivalent immunoprecipitation for HA-Mdm2 and Y276/394F mutant. The control WCE loading was 1/15 th the quantity of protein used for immunoprecipitation. HA-Mdm2 Y405F did not affect co-purification with Myc-Mdmx (Fig. 4C,  lane 3) , whereas the triple mutant HA-Mdm2 Y276/394/405F reduced co-purification to a level similar to that observed for HA-Mdm2 Y276/394F (Fig. 4C, lane 4) . These data show that multi-site phosphorylation of Mdm2 by c-Abl (Y276/394F) is important for optimal Mdm2-Mdmx complex formation. Importantly, these data do not rule out contributing factors provided by additional signaling events that could augment Mdm2-Mdmx complex formation. c-Abl promotes Mdmx ubiquitination. Mdm2 oligomerization in response to DNA damage has been shown to alter Mdm2's E3 ligase function (5) suggesting that phosphorylation of Mdm2 can modulate complex formation to form a unique ligase complex. Examination of the role for c-Abl in ubiquitination of Mdm2 and Mdmx following DNA damage was done by expression of either Abl or KD Abl with HA-Mdm2 and Myc-Mdmx in 293T cells. Transfected cells were treated with 5µM doxorubicin to induce DNA damage and 25µM MG132 to block proteasome activity. Our results revealed an abundance of ubiquitinmodified Mdmx in cells expressing Abl but not in cells expressing KD Abl (Fig. 5A, compare lanes 5  & 10) . The blot was reprobed for ubiquitin, suggesting that the laddering was ubiquitination of Mdmx. We also found that Mdm2 was efficiently ubiquitinated in cells expressing c-Abl but not in cells expressing KD Abl (Fig. 5B, compare lanes 5  & 10) . The lack of ubiquitination in cells expressing KD Abl illustrates the importance of cAbl in response to genotoxic stress. To investigate ubiquitination of endogenous protein, we used cAbl -/-MEFs and Tandem Ubiquitin Binding Entities (TUBEs), which efficiently bind ubiquitinated proteins while also protecting against de-ubiquitination. Our results showed a significant decrease in ubiquitination of endogenous Mdmx in the primary c-Abl -/-MEFs compared to control MEFs in the presence of 25µM MG132 (Fig. 5C ). This result is representative of two independent experiments.
To investigate directly the impact of Abl phosphorylation in Mdm2's ability to ubiquitinate Mdmx, an in vitro ubiquitination assay was performed. Consistent with our expression system and the c-Abl -/-MEFs, our results showed that Abl phosphorylated Mdm2 (Mdm2-P) significantly increased the abundance of ubiquitinated Mdmx compared to non-phosphorylated Mdm2 (Fig. 5D , compare lanes 4 & 5) . Counter blot confirmed the presence of phospho-tyrosine modifications to Mdm2. These data show that c-Abl is important for maximizing ubiquitination of Mdmx following DNA damage.
Inactivation of c-Abl protects Mdm2 and Mdmx and decreases p53 accumulation.
Consistent with an increase in ubiquitination of Mdm2 and Mdmx through the activity of c-Abl, imatinib treated MCF-7 cells showed a protection of endogenous Mdm2 and Mdmx protein levels (Fig. 6A, lane 3) . This suggests a role for c-Abl phosphorylation in basal maintenance of Mdm2 and Mdmx protein in unstressed cells. Under these conditions, p53 levels were unchanged indicating that imatinib treatment alone is not sufficient to induce p53 (Fig. 6A ). This observation is likely the result of the pool of Mdm2 that does not regulate p53 in the absence of DNA damage (33) . To show that imatinib treatment is capable of blocking tyrosine phosphorylation of Mdm2, MCF-7 lysates were immunoprecipitated with Mdm2 antibody and probed for phospho-tyrosine (Fig. 6B, lanes 2 &  4) . In addition, after DNA damage, cells expressing shRNA for gene silencing of c-Abl (25) exhibited a significant increase in Mdmx protein despite only modest c-Abl protein knock down. Mdm2 protein level increased to a lesser degree under these conditions (Fig. 6C, compare  lanes 3 & 4) . Further, p53 accumulates in control cells following DNA damage whereas cells with cAbl protein knock down the accumulation of p53 is significantly attenuated (Fig. 6C, lanes 3 & 4) .
To test the Mdm2 and Mdmx protein levels and p53 accumulation in a cellular system completely lacking c-Abl, we again utilized the cAbl -/-MEFs. In response to DNA damage, the level of endogenous Mdm2 and Mdmx protein in the c-Abl -/-MEFs was more abundant than in control cells (Fig. 6D, compare lanes 3 & 4) . Further, if the Mdm2-Mdmx complex is lending itself to degradation through c-Abl activity then we would expect p53 to be destabilized in the absence of c-Abl following DNA damage. Consistent with this, our results showed that p53 protein was not as robustly induced in c-Abl -/-MEFs in response to DNA damage (Fig. 6D) . This is consistent with previous data showing that cAbl protects p53 (28) . In addition, expression of HA-Mdm2 Y276/394F (c-Abl point mutant) showed a significant destabilization of p53 compared to expression of wild-type HA-Mdm2 (Fig. S1A) . Also, p53 transcriptional activity was significantly reduced in cells treated with imatinib to block c-Abl signaling (Fig. S1B) . These data show that c-Abl is important for reducing Mdm2 and Mdmx protein levels after genotoxic stress and suggest another cellular mechanism for the stabilization and activation of p53.
DISCUSSION
Previous data clearly shows a role for DNA damage-induced phosphorylation of Mdm2 and Mdmx in the stabilization of p53. However, most reports have focused on modulating the direct binding of Mdm2 and Mdmx to p53 or to other effector molecules that lead to their destabilization. Recently, the oligomerization of Mdm2 and Mdmx has attracted much attention as a mechanism for modulating ligase activity. Structural modeling studies of the RING domains of Mdm2 and Mdmx have suggested that heterodimerization provides a mechanism for the recruitment of E2s to the ligase complex and directs target specificity (23) . This report predicts that the Mdm2-Mdmx hetero-dimer would destabilize p53, but our cell-based assays show that endogenous Mdm2 and Mdmx form heterooligomers in response to c-Abl phosphorylation and stabilize p53. Our data also shows that c-Abl phosphorylation of Mdm2 destabilizes Mdmx through an ubiquitin-dependent pathway. These results add an important regulatory mechanism to the formation and functional role of the Mdm2-Mdmx complex.
Our data suggests that multi-site phosphorylation of Mdm2 by c-Abl is important for Mdm2-Mdmx complex formation (Fig. 4) . Further, one of the tyrosine residues important for complex formation is proximal to the RING domain of Mdm2. The placement of this modification provides for potential RING domain structural changes required to modulate interactions. This is consistent with ATM phosphorylation of Mdm2 affecting RING domain homo-dimerization and activity (5) . Importantly, RING domain dimerization appears to be a general requirement for active ligase complex assembly (34) .
In the absence of c-Abl activity, using the cAbl -/-MEFs, we observed a loss of Mdmx ubiquitination following genotoxic stress (Fig.  5C ). Therefore, c-Abl phosphorylation is important not only for Mdm2-Mdmx complex formation but also the full transcriptional potential of p53 via destabilization of Mdmx (13) . In addition, we observed a lack of Mdmx ubiquitination in response to DNA damage when KD Abl was expressed in cells (Fig. 5A ). In these experiments there is evidence of ubiquitination at 1 and 3 h while the most abundant level of ubiquitination was not observed until 6 h. The kinetics of ubiquitination in these experiments, but not the underlying mechanism, is likely driven in part by ectopic expression of Mdm2 and Mdmx. We expected ubiquitination of Mdmx in these experiments even in the presence of KD Abl, since c-Abl is downstream of ATM in the DNA damage-signaling cascade. ATM and ATMdependent Chk1/2 phosphorylation of Mdmx leads to ubiquitin-dependent destabilization of Mdmx (6-9). Thus our results highlight the importance of c-Abl signaling under extreme genotoxic stress and are likely due to the type and severity of DNA damage.
Overall our data suggests a positive effect of c-Abl phosphorylation of Mdm2 in p53 stabilization through destabilization of the Mdm2-Mdmx complex. Whereas the stress response is often associated with activation of Mdm2 under sub-lethal stress response, there are different responses for Mdm2 based on different stress conditions. In general sub-lethal damage is thought to be associated with cycle arrest while severe stress leads to an apoptotic response (27) . It has been proposed by others (5, 35) and supported by these data that modulating the oligomerization of E3 complexes provides a mechanism for control of ubiquitination. Selectively inducing Mdm2-Mdmx complex formation would provide a novel therapeutic target to protect p53 and other tumor suppressors that are negatively regulated by this complex. by guest on January 9, 2018 
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